Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease.
Benitez-Del-Castillo JM, Moreno-Montañés J, Jiménez-Alfaro I, Muñoz-Negrete FJ, Turman K, Palumaa K, Sádaba B, González MV, Ruz V, Vargas B, Pañeda C, Martínez T, Bleau AM, Jimenez AI.
Benitez-Del-Castillo JM, et al. Among authors: jimenez ai, jimenez alfaro i.
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6447-6454. doi: 10.1167/iovs.16-20303.
Invest Ophthalmol Vis Sci. 2016.
PMID: 27893109
Free article.
Clinical Trial.